G1 Therapeutics Ownership | Who Owns G1 Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

G1 Therapeutics Ownership Summary

G1 Therapeutics is owned by 38.21% institutional investors, 10.92% insiders, and 50.86% retail investors. Blackrock is the largest institutional shareholder, holding 5.91% of GTHX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.63% of its assets in G1 Therapeutics shares.

GTHX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	G1 Therapeutics	38.21%	10.92%	50.86%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	3.08M	5.91%	$7.03M
Geode capital management	1.08M	2.07%	$2.46M
State street	827.96K	1.59%	$1.89M
D. e. shaw	767.07K	1.47%	$1.75M
Jacobs levy equity management	463.59K	0.89%	$1.06M
Morgan stanley	401.48K	0.77%	$915.38K
Bridgeway capital management	398.04K	0.76%	$907.54K
Boothbay fund management	349.10K	0.67%	$795.95K
Two sigma investments, lp	308.82K	0.59%	$704.12K
Two sigma advisers, lp	211.70K	0.41%	$482.68K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ikarian capital	12.25K	0.49%	$2.79M
Bridgeway capital management	398.04K	0.02%	$907.54K
Boothbay fund management	349.10K	0.02%	$795.95K
Virtu financial	74.35K	0.01%	$170.00K
Jacobs levy equity management	463.59K	0.00%	$1.06M
Panagora asset management	177.05K	0.00%	$403.68K
Two sigma investments, lp	308.82K	0.00%	$704.12K
D. e. shaw	767.07K	0.00%	$1.75M
Two sigma advisers, lp	211.70K	0.00%	$482.68K
Geode capital management	1.08M	0.00%	$2.46M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	3.08M	0.00%	2.41M
State street	827.96K	0.00%	666.85K
Geode capital management	1.08M	0.00%	573.84K
Boothbay fund management	349.10K	0.02%	349.10K
Morgan stanley	401.48K	0.00%	226.14K

Top Sellers

Holder	Shares	% Assets	Change
Vanguard group	-	-	-2.49M
Woodline partners lp	-	-	-1.36M
Renaissance	-	-	-1.25M
Susquehanna group, llp	-	-	-950.84K
Acadian asset management	-	-	-928.21K

New Positions

Holder	Shares	% Assets	Change	Value
Boothbay fund management	349.10K	0.02%	349.10K	$795.95K
Panagora asset management	177.05K	0.00%	177.05K	$403.68K
Nuveen asset management	66.93K	-	66.93K	$152.60K
Invesco	35.71K	-	35.71K	$81.42K
Alliancebernstein	22.34K	-	22.34K	$50.94K

Sold Out

Holder	Change
Newedge advisors	-200.00
Providence capital advisors	-212.00
Lazard asset management	-298.00
Planning capital management	-320.00
Farther finance advisors	-350.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	100	7.53%	19,937,265	39.36%	38	5.00%	63	21.15%	17	13.33%
Mar 31, 2024	93	3.33%	14,305,888	13.36%	27	4.66%	52	15.56%	15	-48.28%
Dec 31, 2023	90	21.62%	12,619,702	15.31%	24	5.43%	45	28.57%	29	45.00%
Sep 30, 2023	74	-12.94%	10,944,376	-29.44%	21	2.35%	35	6.06%	20	-33.33%
Jun 30, 2023	85	-15.84%	15,510,418	-19.24%	30	2.17%	33	-25.00%	30	-18.92%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.39M	2.63%	-
Arbitrage R	1.31M	2.49%	1.31M
Vanguard Institutional Extnd Mkt Idx Tr	659.13K	1.25%	594.00
Fidelity Canadian Large Cp Mlt Ast Bs O	637.33K	1.21%	637.33K
Fidelity Small Cap Index	505.64K	0.96%	-14.29K
Fidelity Extended Market Index	265.36K	0.50%	6.65K
State St Russell Sm/Mid Cp® Indx NL Cl C	263.37K	0.50%	61.62K
Bridgeway Ultra-Small Company	228.04K	0.43%	206.90K
Vanguard Russell 2000 ETF	198.71K	0.38%	5.00K
AltShares Merger Arbitrage ETF	170.38K	0.32%	170.38K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 05, 2024	Perry Andrew	Chief Commercial Officer	Sell	$3.35K
Jul 05, 2024	MURDOCK TERRY L	Chief Operating Officer	Sell	$6.21K
Jul 05, 2024	Malik Rajesh	Chief Medical Officer	Sell	$6.21K
Jul 05, 2024	Avagliano Mark	Chief Business Officer	Sell	$6.62K
Jul 05, 2024	Umstead John W. V	Chief Financial Officer	Sell	$1.32K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	6
2024 Q2	-	7
2024 Q1	-	19
2023 Q4	-	2
2023 Q3	-	6

GTHX Ownership FAQ

Who Owns G1 Therapeutics?

G1 Therapeutics shareholders are primarily institutional investors at 38.21%, followed by 10.92% insiders and 50.87% retail investors. The average institutional ownership in G1 Therapeutics's industry, Biotech Stocks , is 44.97%, which G1 Therapeutics falls below.

Who owns the most shares of G1 Therapeutics?

G1 Therapeutics’s largest shareholders are Blackrock (3.08M shares, 5.91%), Geode capital management (1.08M shares, 2.07%), and State street (827.96K shares, 1.59%). Together, they hold 9.56% of G1 Therapeutics’s total shares outstanding.

Does Blackrock own G1 Therapeutics?

Yes, BlackRock owns 5.91% of G1 Therapeutics, totaling 3.08M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.03M$. In the last quarter, BlackRock increased its holdings by 2.41M shares, a 358.62% change.

Who is G1 Therapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is G1 Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.49% of its assets in 12.25K G1 Therapeutics shares, valued at 2.79M$.

Who is the top mutual fund holder of G1 Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of G1 Therapeutics shares, with 2.63% of its total shares outstanding invested in 1.39M G1 Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools